Shares of our common stock are listed on the NASDAQ OTC market and trade under the symbol “UEEC“.
For more information, please contact investor@uhpcorp.com
For press and media relations, please contact media@uhpcorp.com
2025 OTC Life Sciences Investor Forum
United Health Products presented at the 2025 Life Sciences Virtual Investor Forum. The full presentation is available below.
Click HERE to download the investor presentation.
Press Releases
-
United Health Products to Present at the Life Sciences Virtual Investor Forum September 18th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com MT. LAUREL, N.J., Sept. 16, 2025 (GLOBE NEWSWIRE) — United Health Products (OTCQB: UEEC), focused on the development and commercialization of innovative wound care technologies, today announced that Brian Thom, Chief Executive Officer, will present live at the Life Sciences…
-
United Health Products Provides Regulatory Status Update
Mount Laurel, New Jersey – July 31, 2025 – United Health Products, Inc. (OTCQB: UEEC) today provided a status update on its discussions with the Food & Drug Administration. As previously disclosed, the Company’s Investigational Device Exemption (IDE) application was disallowed pending resolution of the FDA Warning Letter issued on March 25, 2025, identifying certain violations…
-
United Health Products Provides Regulatory Application Update
Mount Laurel, New Jersey – June 6, 2025 – United Health Products, Inc. (OTCQB: UEEC) today provided a status update on its discussion with the Food & Drug Administration. As previously disclosed, the review by FDA’s Office of Product Evaluation and Quality of its Investigational Device Exemption (IDE) application to conduct the follow-on clinical study of…
-
United Health Products Announces OTCQB Uplisting and FDA Update
Mount Laurel, New Jersey – May 1, 2025 – United Health Products, Inc. (OTCQB: UEEC) is pleased to announce that it has been approved to have its common shares uplisted from the OTC “Pink” market to the OTCQB Venture Market (“OTCQB”). The successful uplisting is effective May 1, 2025 and the company’s common shares will continue…